An alliance between industry and academia created by Cancer Research UK has discovered a new approach to targeting key cancer-linked proteins previously deemed ‘undruggable’.
More than 4,500 people from Liverpool with diabetes are taking part in a new a clinical trial designed to help transform early detection of diabetic eye disease.